Long Survival of a Small-Cell Lung Cancer Patient Who Received Maintenance Chemotherapy with Irinotecan

Lung cancer is the leading cause of cancer-related death worldwide. Small-cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers. It is characterized by rapid tumor growth and early metastasis to multiple organs. Response to initial chemotherapy is generally good; however, the ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Yoshitaka, Kim, Young Hak, Tajima, Noriyuki, Baba, Kiichiro, Aihara, Kensaku, Soo, Hong Hyun, Yamaoka, Shinpachi, Mishima, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: November, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861861/
https://www.ncbi.nlm.nih.gov/pubmed/24348395
http://dx.doi.org/10.1159/000356826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861861/
https://www.ncbi.nlm.nih.gov/pubmed/24348395
http://dx.doi.org/10.1159/000356826

Ejemplares similares